No Data
No Data
Talphera Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative...
Talphera to Participate at A.G.P. Virtual Healthcare Conference
Optimistic Buy Rating for Talphera Despite Phase 3 Trial Enrollment Delay
Talphera Shares Are Trading Higher After the Company Reported Better-than-expected Q1 GAAP EPS Results.
Talphera Shares Are Trading Higher After the Company Reported Better-than-expected Q1 GAAP EPS Results.
Analysts Are Bullish on These Healthcare Stocks: Talphera (TLPH), NexGel Inc (NXGL)
Earnings Call Summary | Talphera(TLPH.US) Q1 2024 Earnings Conference
The following is a summary of the Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript:Financial Performance:Talphera reported no revenues for Q1 2024, with cash operating expenses totaling $3.9 mil
No Data